Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared, though it is better positioned in some areas than before COVID-19 due to investments in stockpiles, surveillance, coordination structures, and medical countermeasures. Significant gaps in leadership/coordination, sustained funding, implementation of lessons learned, public trust, supply chains, and workforce remain, leaving the country vulnerable to another major pandemic or widespread health crisis. Recent developments have raised additional concerns about erosion of capabilities.[1]

Progress Since COVID-19

The COVID-19 pandemic (over 1 million US deaths) exposed major weaknesses but also drove improvements:

For ongoing threats like H5N1 (widespread in US dairy cattle, poultry, and wildlife since 2024, with dozens of mostly mild human cases linked to animal exposure and limited fatalities), agencies have distributed PPE, monitored exposed workers (thousands), stocked antivirals (e.g., millions of courses of oseltamivir expected to work), and maintained vaccine components. The risk to the general public has been assessed as low so far, with One Health coordination involving USDA, CDC, ASPR, and FDA.[6]

Persistent Gaps and Criticisms

Experts, bipartisan commissions, GAO, and analyses consistently highlight incomplete readiness:

Bottom Line and Path Forward

The US has stronger physical stockpiles, better data systems, dedicated offices, and technological foundations (e.g., rapid vaccine platforms) than in 2019. It can mount responses to contained outbreaks and has tools for known threats like influenza variants. However, it is not adequately prepared for a novel, highly transmissible/virulent pathogen causing widespread disruption, due to incomplete lesson implementation, funding instability, coordination shortfalls, trust deficits, and variable political prioritization. Biological threats (natural, accidental, or deliberate) are real and growing with climate change, globalization, and tech advances.[11]

Full preparedness requires sustained bipartisan investment, implementing remaining GAO/commission recommendations, rebuilding trust through transparent science-based communication, strengthening public health infrastructure at all levels, securing supply chains, and maintaining “always-on” capabilities rather than crisis-only responses. Without this, the next crisis risks repeating or exceeding COVID’s human and economic costs (estimated in the trillions). Assessments from bipartisan experts, GAO, and public health leaders align on the need for urgent, consistent action.